Christopher Yea Insider Profile

4 Followers
Christopher Yea, CDO at KalVista Pharmaceuticals, holds 85.68K shares in KalVista Pharmaceuticals (Ticker: KALV).
tipranks
Christopher Yea

Christopher Yea
KalVista Pharmaceuticals (KALV)
CDO

Not Ranked
Christopher Yea has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$964K
100.00%
A breakdown of Christopher Yea's holdings

Insider Roles

KalVista Pharmaceuticals
(KALV)
CDO
Roles that Christopher Yea holds in companies

Most Profitable Insider Trade

Stock:
KalVista Pharmaceuticals
(KALV)
Rating:Informative Sell
Date:Feb 16, 2024 - Today
Return:+28.60%
The most profitable trade made by Christopher Yea

Christopher Yea's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
KalVista Pharmaceuticals
Aug 26, 2024
CDO
Uninformative Buy
15.02K
$963.86K
Success Rate for
KALV
1 out of 1 profitable transactions on
KALV
100%
Average Return for
KALV
Average return per transaction on
KALV
+28.60%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 13, 2024
Uninformative Buy
$0.00
-
$0.00
Jan 24, 2019
Uninformative Buy
$31.47K
-
$16.54
Jan 29, 2019
Uninformative Buy
$98.81K
-
$18.12
Jul 24, 2019
Uninformative Buy
$134.82K
-
$18.33
Dec 16, 2019
Uninformative Buy
$79.08K
-
$16.79
List of latest transactions for each holding click on a transaction to see Christopher Yea's performance on stock

Christopher Yea insider profile FAQ

What is the percentage of profitable transactions made by Christopher Yea?
The percentage of profitable transactions made by Christopher Yea is ―.
    What is the average return per transaction made by Christopher Yea?
    The average return per transaction made by Christopher Yea is ―.
      What stocks does Christopher Yea hold?
      Christopher Yea holds: KALV stocks.
        What was Christopher Yea’s latest transaction?
        Christopher Yea latest transaction was an Uninformative Buy of $15.02K.
          What was Christopher Yea's most profitable transaction?
          Christopher Yea’s most profitable transaction was an Informative Sell of KALV stock on February 16, 2024. The return on the trade was 28.60%.
            What is Christopher Yea's role in KalVista Pharmaceuticals?
            Christopher Yea's role in KalVista Pharmaceuticals is CDO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.